Clinical

Dataset Information

0

Cancer therapy with vaccination using HLA-A24-restricted peptide from RNF43:a phase I study in patients with unresectable colorectal cancer


ABSTRACT: Interventions: vaccination Primary outcome(s): safety Study Design: Single arm Non-randomized

DISEASE(S): Unresectable Colorectal Cancer

PROVIDER: 2616206 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2616285 | ecrin-mdr-crc
| 2616208 | ecrin-mdr-crc
| 2616205 | ecrin-mdr-crc
| 2616404 | ecrin-mdr-crc
| 2616207 | ecrin-mdr-crc
| S-EPMC6676125 | biostudies-literature
| 2620437 | ecrin-mdr-crc
| 2621744 | ecrin-mdr-crc
| 2620402 | ecrin-mdr-crc
| 2623214 | ecrin-mdr-crc